DNA - ©Microverse StudiosOur focus
We’re a leading healthcare company in China.
Our interests span earlier-stage, differentiated assets through late-stage and marketed products and opportunities in digital health.
Sanofi in Suzhou
At the Sanofi Institute for Biomedical Research in Suzhou, the hub of China’s R&D ecosystem, we’re elevating our early research capabilities in oncology and immuno-inflammation.
DNA is converted into a binary code. Concept binary code genome. Abstract technology science, concept artifical DnaDigital Health
We’re one of the first pharma companies to launch our own virtual healthcare service, Amulet Health Technology, which leverages our global network to provide integrated care for chronic disease patients worldwide, with a particular focus on Asia.
Partnering Success Stories
Cathay Innovation
This investment helps us engage with innovative healthcare technologies in China.
CR Pharmaceutical
Together we’re exploring consumer healthcare opportunities in China to promote self-care and wellness.
Innovent
We’re collaborating to accelerate the development of oncology medicines for cancer patients and expand our presence in China.
Our Partnering Lead in China
For more information, contact us at ChinaBD@sanofi.com
Ying Yang
Greater China Strategy & Business Development Head